Skip to main content
Bayer CropScience Limited. logo

Bayer CropScience Limited. — Investor Relations & Filings

Ticker · BAYERCROP ISIN · INE462A01022 LEI · 529900XEDZLQSXJY7F33 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 735 across all filing types
Latest filing 2023-05-27 Regulatory Filings
Country IN India
Listing BSE.NS BAYERCROP

About Bayer CropScience Limited.

https://www.bayer.in/en-in

Bayer CropScience Limited specializes in the development and distribution of agricultural solutions focused on crop protection and seeds. The company’s portfolio includes a wide range of insecticides, fungicides, and herbicides tailored to manage pests, diseases, and weeds across various crop cycles. It also produces high-yielding hybrid seeds for key crops including corn, rice, cotton, and various vegetables. Beyond chemical and biological products, the organization integrates digital farming technologies to provide precision agriculture tools and data-driven insights for yield optimization. Its operations emphasize sustainable productivity and integrated crop management, targeting smallholder and large-scale farmers. The company leverages global research and development capabilities to deliver innovative solutions aimed at improving food security and agricultural efficiency.

Recent filings

Filing Released Lang Actions
In terms of Regulation 47 read with Schedule III Part A Para A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the publication of audited financial results for the year ended March 31, 2023. It includes an extract of financial results for the quarter and year ended March 31, 2023, published as a newspaper advertisement. The letter references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and states that the full detailed financial results are available on the stock exchange and company websites. The document itself is a notification of the publication of financial results in newspapers and on the website, not the full annual report or detailed financial statements. It is essentially an announcement of the audited financial results rather than the report itself. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Regulatory Filing (RNS) because it is a regulatory announcement of financial results publication, not the full Annual Report (10-K) or Interim Report (IR).
2023-05-27 English
Pursuant to SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 08, 2019, read with Regulation 24A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) ...
Regulatory Filings
2023-05-25 English
Please take note that the Investor Meet of Bayer CropScience Limited is scheduled to be held on Thursday, June 01, 2023, at 04:00 p.m. IST and the presentation for the same will be uploaded ....
Investor Presentation Classification · 90% confidence The document is a short notice informing about an upcoming Investor Meet scheduled for June 1, 2023, and mentions that the presentation will be uploaded before the meeting. It is an intimation letter sent to the stock exchange as per regulatory requirements (SEBI Listing Obligations). The document does not contain any financial data, detailed presentation, or report itself, but only announces the event and the forthcoming presentation. The length is only 1383 characters, which is quite short and fits the pattern of an announcement rather than a full report or presentation. Therefore, this document is best classified as an Investor Presentation (IP) announcement or intimation. However, since the actual presentation is not included and only the meeting and presentation upload are announced, it aligns with the Investor Presentation category as it relates to investor communication about financials and strategy.
2023-05-25 English
We enclose herewith a Statement on Related Party Transactions of the Company for the half year ended as on March 31, 2023 in terms of Regulation 23(9) of SEBI (Listing Obligations and Disclosure ....
Regulatory Filings Classification · 95% confidence The document is a detailed disclosure of related party transactions for Bayer CropScience Ltd. for the half year ended March 31, 2023. It references Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates such disclosures. The content includes extensive tables listing transactions with related parties, amounts, approvals, and other financial details. This is a regulatory compliance disclosure specific to related party transactions rather than a full financial report or earnings release. It is not an announcement of a report but the actual disclosure document itself. Such disclosures are typically filed as Regulatory Filings (RNS) under SEBI regulations as they do not fit into other categories like Annual Report, Interim Report, or Earnings Release. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-05-24 English
We send herewith a copy of the News Release that is being issued by the Company today, in connection with the Audited Financial Results for the financial year ended on March 31, 2023. You ....
Earnings Release Classification · 95% confidence The document is a news release announcing the audited financial results for the full fiscal year ended March 31, 2023, and the fourth quarter results. It contains key financial highlights such as revenue, profit before tax, and exceptional items, along with management commentary on the results. The document is about 5,238 characters long, which is sufficient to include substantive financial data and analysis, not just a brief announcement or a link to a report. It is not a full annual report (10-K) but rather a press release summarizing the financial results. This fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights. Therefore, the appropriate classification is ER with high confidence.
2023-05-24 English
We wish to inform that at the Board Meeting of the Company held on May 24, 2023, the Board of Directors approved the Audited Financial Results for the year ended March 31, 2023 and recommended ....
Regulatory Filings
2023-05-24 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.